The Cognitive Neurology and Alzheimer Research Centre (CNARC) is a specialized clinic for the investigation of neurodegenerative disease and research on the clinical features, causes, diagnosis, and treatments of these diseases.
CNARC provides consulting services and has developed major research programs. We have established several treatment programs for Alzheimer's disease and have specialized expertise in Pick's disease and focal atrophies. Our research interests include the use of functional MRI to examine affect and behavioral changes in Frontotemporal Dementia, the genetics of dementia, use of MRI for early diagnosis of dementia, and the basic cell biology of neurodegenerative disease.
CNARC participates in multicenter academic and pharmaceutical company sponsored research. Examples of these include the NIH-sponsored Alzheimer's Disease Neuroimaging Initiative (ADNI), and the major clinical trials from Elan (Bapaneuzimab and Scyllo-insitol) and Myriad (Flurizan).
Our staff consists of two neuropsychometricians, a research assistant, two nurse coordinators for drug trials, and an administrative/regulatory assistant.